000			01187nam a2200193Ia 4500
003			OSt
005			20240408122659.0
008			220515s9999||||xx |||||||||||||| ||und||
040			_cAMIU
050			_aWC503.2 W 46 2010
100			_aWHO
245		0	_aHIV drug resistance Early warning indicators
260			_aGeneva,Switzerland _b(WHO)World Health Organization _c2010
300			_a45p
500			_aDescribes the key element in the recommended HIV Drug Resistance prevention and assessment strategy by the WHO which includes: ART site based HIV Drug Resistance (HIVDR) Early Warning Indicators. Includes indicators such as ART prescribing practices, patients lost to follow-up 12 months after ART initiation, patients on appropriate first-line ART at 12 months, on-time ARV drug pick-up, ART clinic appointment keeping, ARV drug supply continuity, optional early warning indicators. Demonstrates how results can inform national decision-making on ART programme planning and other HIV drug resistance prevention measures.
583			_aCataloging Notes: _c20240408 _kAMIU-3094AMIU-3094
650			_aDrugs|Art|Human immunodeficiency virus|Drug Resistance|Treatment
942			_2lcc _cBK
999			_c7526 _d7526